Search

Michael Konrad Phones & Addresses

  • 2406 Alamo Glen Dr, Alamo, CA 94507
  • Elko, NV
  • San Francisco, CA
  • Union City, CA
  • Redwood City, CA
  • Palo Alto, CA
  • Fountain Valley, CA
  • Danville, CA
  • 22 Ardith Ln, Alamo, CA 94507

Work

Company: Genevue, inc. Address: 1199 Camino Vallecito, Lafayette, CA 94549 Phones: (510) 295-9810 Position: Manager Industries: Nonclassifiable Establishments

Resumes

Resumes

Michael Konrad Photo 1

Named Account Manager

View page
Location:
San Francisco, CA
Industry:
Computer Software
Work:
Genesys Mar 2013 - Mar 2017
Director of Sales-Enterprise Account Executive

Avaya Mar 2013 - Mar 2017
Named Account Manager

Utopy May 2009 - Mar 2013
Director of Sales-Enterprise Account Executive

Everge Group Jun 2008 - May 2009
Sale Manager

Oracle Feb 2006 - Jun 2008
Crm Senior Regional Manager, Applications Sales
Education:
Uc Santa Barbara 1985 - 1987
Bachelors, Bachelor of Arts, Business Economics, Business
Skills:
Solution Selling
Business Intelligence
Enterprise Software
Crm
Sales Operations
Selling
Sales Management
Sales
Management
Complex Sales
Saas
Professional Services
Software Industry
Salesforce.com
Sales Process
Sales Enablement
Siebel
Direct Sales
Michael Konrad Photo 2

Michael Konrad

View page
Michael Konrad Photo 3

Michael Konrad

View page
Location:
United States

Business Records

Name / Title
Company / Classification
Phones & Addresses
235 Montgomery St STE 825, San Francisco, CA 94104
Michael Konrad
Manager
Genevue, Inc.
Nonclassifiable Establishments
1199 Camino Vallecito, Lafayette, CA 94549
Michael Konrad
Owner
Aqueous Technologies Corp
Durable Goods
9055 Rancho Park Ct, Rancho Cucamonga, CA 91730
Website: aqueoustech.com
Michael Konrad
President
Science Is Art
Entertainment · Business Services at Non-Commercial Site
38 Santa Rosa Ave, Sausalito, CA 94965
Michael Konrad
President, CEO
ASKNET, INC
Telephone Communications
235 Montgomery St SUITE 825, San Francisco, CA 94104
303 S Broadway STE 224, Tarrytown, NY 10591
(415) 352-2610, (415) 449-5700, (415) 352-2611
Michael Konrad
President
GENEVUE, INC
38 Santa Rosa Ave, Sausalito, CA 94965
(415) 339-9134
Michael Konrad
President
TRANZ MICROWAVE CORP
535 Romona St #718, Palo Alto, CA 94301
535 Ramona St, Palo Alto, CA 94301
Michael Konrad
Precision Machining LLC
Machine Shop · Metal Restoration
2150 Rheem Dr, Pleasanton, CA 94588
(925) 846-8009
Michael Konrad
Manager
Genevue, Inc.
Nonclassifiable Establishments
1199 Camino Vallecito, Lafayette, CA 94549
Michael Konrad
Owner
Aqueous Technologies Corp
Durable Goods
9055 Rancho Park Ct, Rancho Cucamonga, CA 91730
Website: aqueoustech.com

Publications

Isbn (Books And Publications)

Das Schulfacherspektrum Im Rahmen Einer Theorie Der Erziehung

View page
Author

Michael Konrad

ISBN #

3589205180

Werte versus Normen Als Handlungsgrunde

View page
Author

Michael Konrad

ISBN #

3906765113

Findbuch Stadtarchiv Wendlingen Am Neckar

View page
Author

Michael Konrad

ISBN #

3933235022

Findbuch Stadtarchiv Wendlingen Am Neckar

View page
Author

Michael Konrad

ISBN #

3933235030

Findbuch Gemeindearchiv Bissingen an Der Teck

View page
Author

Michael Konrad

ISBN #

3933235073

Findbuch Gemeindearchiv Bissingen an Der Teck

View page
Author

Michael Konrad

ISBN #

3933235081

Us Patents

Optical Detection Of Position Of Oligonucleotides On Large Dna Molecules

View page
US Patent:
57891672, Aug 4, 1998
Filed:
Feb 13, 1996
Appl. No.:
8/596159
Inventors:
Michael W. Konrad - Lafayette CA
Assignee:
GeneVue, Inc. - Lafayette CA
International Classification:
C12Q 168
C07H 2104
C07H 2102
US Classification:
435 6
Abstract:
A method for analyzing a sample oligonucleotide sequence is described. The method comprises contacting the sample oligonucleotide sequence with an anchor sequence which comprises an immobilized oligonucleotide sequence which hybridizes with the sample. The sample is also contacted with a probe comprising an oligonucleotide sequence which hybridizes to a target oligonucleotide sequence to be detected in a suitable buffer to form a complex. The complex is subjected to a field which moves unbound oligonucleotide sequences away from the anchor sequence in the direction of the field, and preferably, extends the sample sequence. Whether the probe is bound to the sample oligonucleotide sequence, and preferably, the position of the probe, is determined to determine whether the target oligonucleotide sequence is present in the sample. The method can be used for mapping, for identity typing, and to determine whether a test oligonucleotide sequence is present in the sample. A device for performing the method and reagents are also described.

Process For Recovering Human Ifn-.Beta. From A Transformed Microorganism

View page
US Patent:
44501030, May 22, 1984
Filed:
Mar 1, 1982
Appl. No.:
6/353360
Inventors:
Michael W. Konrad - Alameda CA
Leo S. Lin - Fremont CA
Assignee:
Cetus Corporation - Emeryville CA
International Classification:
C07G 700
C12P 2100
C12P 2102
A61K 4502
US Classification:
260112R
Abstract:
A process for recovering IFN-. beta. from transformed bacteria comprising: disrupting the cell membranes of the bacteria; solubilizing the IFN-. beta. from the disruptate into an aqueous medium with a solubilizing agent such as sodium dodecyl sulfate; extracting the IFN-. beta. from the aqueous medium with 2-butanol, 2-methyl-butanol, or mixtures thereof under conditions that maintain phase separation between the aqueous meduim and the extractant; and isolating the IFN-. beta. from the extractant such as by precipitating the IFN-. beta. from an aqeous buffer mixture of the extractant by lowering the pH thereof.

Bacterial Production Of Heterologous Polypeptides Under The Control Of A Repressible Promoter-Operator

View page
US Patent:
44991886, Feb 12, 1985
Filed:
May 5, 1982
Appl. No.:
6/375098
Inventors:
Michael W. Konrad - Alameda CA
David F. Mark - Hercules CA
Assignee:
Cetus Corporation - Emeryville CA
International Classification:
C12P 2102
C12P 2100
C12N 1500
US Classification:
435 70
Abstract:
A process for bacterially producing heterologous polypeptides, particularly those such as human IFN-. beta. that inhibit bacterial growth, in which bacteria that have been transformed to express the heterologous polypeptide under the control of a trp promoter-operator are cultivated in a known volume of medium containing an excess of a preferred carbon source such as glucose and a predetermined amount of tryptophan that corresponds approximately to the amount of tryptophan contained in the bacteria in the volume of medium at a predetermined elevated cellular density, whereby expression of the heterologous polypeptide is substantially repressed until the bacteria grow to approximately the predetermined elevated cellular density and is thereafter automatically derepressed to permit expression of the heterologous polypeptide.
Michael Patrick Konrad from Alamo, CA, age ~60 Get Report